ArticleThe oncologist2019

Exploring Patient Decision Making Regarding Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.

Kathryn E Flynn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.